NASDAQ:TLRY - Nasdaq - US88688T1007 - Common Stock - Currency: USD
TILRAY BRANDS INC
NASDAQ:TLRY (2/5/2025, 7:45:54 PM)
After market: 1.0799 +0.01 (+0.93%)1.07
+0.07 (+7%)
The current stock price of TLRY is 1.07 USD. In the past month the price decreased by -23.57%. In the past year, price decreased by -43.09%.
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Tobacco company Philip Morris International (NYSE:PM) will be announcing earnings results tomorrow before market hours. Here’s what to look for.
JetBlue to Serve Montauk Brewing's Surf Beer Golden Ale on All Domestic and International Flights
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 82.81 | 799.50B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 29.06 | 380.66B | ||
JNJ | JOHNSON & JOHNSON | 15.48 | 372.43B | ||
MRK | MERCK & CO. INC. | 11.74 | 226.83B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.62 | 219.96B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 219.54B | ||
PFE | PFIZER INC | 8.5 | 149.84B | ||
SNY | SANOFI-ADR | 13.51 | 134.13B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 51.03 | 121.10B | ||
ZTS | ZOETIS INC | 30.5 | 79.26B | ||
GSK | GSK PLC-SPON ADR | 9.11 | 76.92B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.09 | 42.39B |
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. The company is headquartered in New York City, New York and currently employs 2,650 full-time employees. The company went IPO on 2018-07-19. The firm operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The firm offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
TILRAY BRANDS INC
655 Madison Avenue, 19th Floor
New York City NEW YORK V9X 1J2 US
CEO: Irwin D. Simon
Employees: 2650
Company Website: https://www.tilray.com/
Investor Relations: https://ir.tilray.com/
Phone: 15193228800
The current stock price of TLRY is 1.07 USD.
The exchange symbol of TILRAY BRANDS INC is TLRY and it is listed on the Nasdaq exchange.
TLRY stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TLRY, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TLRY.
TLRY does not pay a dividend.
TLRY does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.3).
The outstanding short interest for TLRY is 14.92% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to TLRY. TLRY has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months TLRY reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS decreased by 86.05% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -5.94% | ||
ROE | -7.17% | ||
Debt/Equity | 0.1 |
ChartMill assigns a Buy % Consensus number of 72% to TLRY. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 40.17% and a revenue growth 14.2% for TLRY